Let’s uncover some gems from our specialized screener.<\/p>\n
Simply Wall St Value Rating: \u2605\u2605\u2605\u2605\u2605\u2605<\/p>\n
Overview: Zaptec ASA focuses on developing and selling electric car chargers and charging systems across various countries including Norway, Sweden, Switzerland, Denmark, Iceland, and other international markets with a market cap of NOK3.57 billion.<\/p>\n
Operations: Zaptec ASA generates revenue primarily from the sale of electric car chargers and charging systems. The company operates in multiple international markets, contributing to its diverse revenue streams. Its financial performance is influenced by factors such as production costs and market demand across these regions.<\/p>\n
Zaptec, a promising player in the European market, has shown impressive financial health by eliminating its debt over the past five years. This achievement is underscored by its recent profitability and high-quality earnings. The company reported a net income of NOK 18.71 million for Q1 2026, turning around from a net loss of NOK 7.71 million in the same period last year. Furthermore, Zaptec’s revenue surged to NOK 456.92 million from NOK 346.85 million year-on-year, reflecting robust growth prospects with earnings forecasted to grow at nearly 30% annually. Despite this volatility in share price recently suggests investors should exercise caution while considering this stock as an investment opportunity.<\/p>\n
Story Continues <\/p>\n
OB:ZAP Debt to Equity as at May 2026 <\/p>\n
Simply Wall St Value Rating: \u2605\u2605\u2605\u2605\u2605\u2605<\/p>\n
Overview: MedCap AB (publ) is a private equity firm that focuses on investments in various stages such as industry consolidation, add-on acquisitions, and buyouts, with a market cap of approximately SEK7.64 billion.<\/p>\n
Operations: MedCap generates revenue through its investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature stages, turnarounds, and buyouts. It has a market capitalization of approximately SEK7.64 billion.<\/p>\n
MedCap, a nimble player in the life sciences sector, showcases robust financial health with its debt to equity ratio trimmed from 18% to 14.2% over five years. The firm enjoys high-quality earnings and covers interest payments comfortably at 8.1 times EBIT. Recent results highlight a revenue increase to SEK 564.6 million from SEK 498.3 million year-over-year, while net income rose to SEK 55.9 million from SEK 50.5 million, reflecting solid performance despite industry challenges. Trading at nearly 20% below estimated fair value, MedCap offers potential upside for those eyeing value opportunities in Europe\u2019s dynamic market landscape.<\/p>\n
OM:MCAP Earnings and Revenue Growth as at May 2026 <\/p>\n
Simply Wall St Value Rating: \u2605\u2605\u2605\u2605\u2605\u2605<\/p>\n
Overview: MBB SE, with a market cap of \u20ac1.14 billion, is involved in acquiring and managing medium-sized companies both in Germany and internationally through its subsidiaries.<\/p>\n
Operations: MBB SE generates revenue primarily through its subsidiaries, with significant contributions from Friedrich Vorwerk (\u20ac704.33 million) and Aumann (\u20ac203.99 million). The company’s net profit margin reflects its overall profitability, influenced by the performance of these key segments.<\/p>\n
MBB, a dynamic player in the Industrials sector, saw its earnings surge 34.8% last year, outpacing the industry\u2019s 8.3%. With a debt-to-equity ratio dropping from 11% to 3.4% over five years and more cash than total debt, financial health seems robust. Trading at about 20.5% below fair value estimates adds appeal for potential investors. The recent announcement of an annual dividend of \u20ac1.21 per share reflects confidence in sustained profitability despite forecasts indicating a potential average earnings decline of 4.2% annually over the next three years, highlighting both opportunities and challenges ahead for MBB’s growth trajectory.<\/p>\n
XTRA:MBB Debt to Equity as at May 2026 Make It Happen Interested In Other Possibilities? <\/p>\n
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.<\/p>\n
Companies discussed in this article include OB:ZAP OM:MCAP and XTRA:MBB.<\/p>\n
Have feedback on this article? Concerned about the content? Get in touch<\/a> with us directly. Alternatively, email editorial-team@simplywallst.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"As the European markets navigate a landscape marked by stable interest rates and fluctuating economic sentiment, investors are…\n","protected":false},"author":2,"featured_media":14339,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[526,20559,4,483,643,1838,351,23318,2188],"class_list":{"0":"post-35185","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-europe","8":"tag-debt-to-equity","9":"tag-earnings-momentum","10":"tag-europe","11":"tag-european-markets","12":"tag-financial-health","13":"tag-potential","14":"tag-revenue-growth","15":"tag-stable-interest-rates","16":"tag-undiscovered-gems"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/posts\/35185","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/comments?post=35185"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/posts\/35185\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/media\/14339"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/media?parent=35185"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/categories?post=35185"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/tags?post=35185"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}